The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | D | Dermatologicals | |
| 2 | D07 | Corticosteroids, dermatological preparations | |
| 3 | D07A | Corticosteroids, plain | |
| 4 | D07AC | Corticosteroids, potent (group III) | |
| 5 | D07AC09 | Budesonide |
| Active Ingredient | Description | |
|---|---|---|
| Budesonide |
Budesonide is a glucocorticosteroid with a high local anti-inflammatory effect. At doses clinically equivalent to systemically acting glucocorticosteroids, budesonide gives significantly less HPA axis suppression and has a lower impact on inflammatory markers. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| BUDESONIDE 64 Aqueous Nasal Spray | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| BUDESONIDE Nebuliser Suspension | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
